Epigenetic Aging Markers Predict Lung Cancer Beyond Traditional Smoking Measures
Three epigenetic aging markers—AgeAccelPheno, AgeAccelGrim, and DunedinPACE—correlated significantly with total nicotine equivalents in urine, a precise…
Found 2031 results for "cancer"
Three epigenetic aging markers—AgeAccelPheno, AgeAccelGrim, and DunedinPACE—correlated significantly with total nicotine equivalents in urine, a precise…
Analysis of 1,468 colorectal cancer screening participants revealed that each 10-gram daily increase in alcohol consumption raises advanced lesion odds by 9%…
Early identification of which blood abnormalities will progress to childhood leukemia could transform treatment decisions for infants with Down syndrome, who…
Cancer prevention strategies may become more targeted after researchers definitively established that all esophageal adenocarcinomas develop through a single…
Common respiratory infections may inadvertently create a protective shield against cancer spread to the lungs, challenging conventional thinking about viral…
Cancer immunotherapy faces a critical bottleneck: delivering mRNA vaccines that can both reach target cells and trigger robust immune responses. Most current…
The ability to watch molecular processes unfold within individual living cells could revolutionize precision medicine and our understanding of disease…
The ability of cells to recover their reproductive capacity after doubling their entire genetic content may depend on a previously unrecognized chromosomal…
Pancreatic cancer's devastating 95% five-year mortality rate stems largely from its silent progression until advanced stages, when treatment options become…
Brain cancer researchers have uncovered why certain childhood medulloblastomas become so aggressively treatment-resistant, potentially opening new therapeutic…
Solid tumors have proven stubbornly resistant to CAR T cell immunotherapy, which has revolutionized blood cancers but struggles against the protective…
Pancreatic cancer remains one of the most lethal malignancies, with five-year survival rates below 10 percent. Finding effective first-line treatments that…
Glioblastoma represents one of medicine's most formidable challenges, with median survival rarely exceeding 15 months despite aggressive treatment. The…
Advanced kidney cancer traditionally carries a poor prognosis, with most patients experiencing disease progression despite multiple treatment attempts. This…
Triple-negative breast cancer represents one of oncology's most frustrating puzzles, lacking the hormone receptors that make other breast cancers treatable…
Advanced cancer patients face diminishing treatment options as tumors develop resistance to conventional therapies, making novel combination approaches…
The pursuit of healthy aging takes on new urgency as evidence mounts that cardiovascular fitness during middle age fundamentally reshapes the trajectory of…
Cancer survivors carrying emotional wounds from childhood face a compounding burden that extends far beyond their oncological journey. The intersection of…
Cancer patients receiving advanced CAR-T cell immunotherapy can now breathe easier knowing that the treatment's most concerning side effects follow a…
Understanding how certain skin cancers become aggressively invasive could transform early detection and treatment strategies for one of the most rapidly…